Adherex Technologies Announces Strengthened Intellectual Property Portfolio; New US Patent Expands Potential of Technology Application.Business Editors & Health/Medical Writers OTTAWA--(BUSINESS WIRE)--April 11, 2002 Adherex Technologies Inc. (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :AHX AHX American History X (movie) AHX Abyss' Highest eXperience ), a biotechnology company developing novel therapeutics based on cell adhesion Cellular adhesion is the binding of a cell to another cell or to a surface or matrix. Cellular adhesion is regulated by specific adhesion molecules that interact with molecules on the opposing cell or surface. technology, today announced it was issued a new US patent which allows the company to potentially broaden its platform technology. The company's 13th US patent relates to nonclassical cadherins and will provide Adherex with protection for synthetic drugs designed to disrupt VE-cadherin. This cell adhesion protein is expressed by blood vessel blood vessel n. An elastic tubular channel, such as an artery, a vein, a sinus, or a capillary, through which the blood circulates. blood vessel(s), n the network of muscular tubes that carry blood. cells but is different from the target of Exherin, Adherex's lead vascular targeting agent. "The scientific community has recognized the importance of this type of compound, including in a peer-reviewed article appearing in the scientific journal, Blood (March 2001). We believe these compounds fit perfectly into our approach of effectively starving cancer tumors by attacking the blood vessels Blood vessels Tubular channels for blood transport, of which there are three principal types: arteries, capillaries, and veins. Only the larger arteries and veins in the body bear distinct names. that feed them," said John Brooks For the British life peer, see . For the officer in the US Marine Corps, see . John Brooks (May 4, 1752 – March 1, 1825) was Governor of Massachusetts from 1816 to 1823. , President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Adherex. "This intellectual property allows us to broaden our approach in targeting the cadherins that help hold the blood vessels together." About Adherex Technologies Adherex Technologies is an Ottawa-based biotechnology company that develops therapeutic drugs based upon its proprietary cell adhesion platform technology. The lead compound, Exherin, works to destroy the blood vessels that feed a cancerous tumor, essentially destroying the tumor's food supply. Adherex's unique cell adhesion platform has the potential for diverse applications, including drug delivery through the skin. For more information, please visit Adherex's Web site at www.adherex.com. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Certain information contained in this news release is forward-looking and is subject to unknown risks and uncertainties. The actual results, performance or achievements of the company may differ materially from the results, performance or achievements of the company expressed or implied by such forward looking statements. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion